The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDialight Regulatory News (DIA)

Share Price Information for Dialight (DIA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 160.50
Bid: 152.00
Ask: 169.00
Change: 0.00 (0.00%)
Spread: 17.00 (11.184%)
Open: 160.50
High: 0.00
Low: 0.00
Prev. Close: 160.50
DIA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

9 Jan 2018 11:15

RNS Number : 3603B
Dialight PLC
09 January 2018
 

 

Dialight plc (the "Company")

 

Director/PDMR Shareholding

 

9 January 2018

 

The Company has been notified that, on 9 January 2018 Stephen Bird, a Non-Executive Director of the Company, purchased a total of 10,000 ordinary shares of £0.0189 each in the Company (the ''Transaction'').

 

Following the Transaction, Stephen Bird now holds a total of 38,000 ordinary shares, representing 0.12% of the total issued share capital of the Company.

 

This notification was received by the Company on 9 January 2018 and was made in accordance with the Market Abuse Regulation and Disclosure Transparency Rules.

 

The details of the Transaction are as follows:

 

1.

Details of the person discharging managerial responsibilities/person closely associated

(a)

Name

Stephen Bird

2.

Reason for the notification

(a)

Position/status

Non-Executive Director

(b)

Initial notification/ Amendment

Initial notification

3.

Details of the issuer

(a)

Name

Dialight plc

(b)

LEI

2138001AD31KKD29Z495

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary shares of £0.0189 each

(b)

Identification code of the Financial Instrument

GB0033057794

(c)

Nature of the transaction

Purchase of shares

(d)

Price(s) and volume(s)

Price(s)

Volume(s)

£5.90

10,000

(e)

Aggregated information

- Aggregated volume

- Price

 

10,000

£5.90

(f)

Date of the transaction

9 January 2018

(g)

Place of the transaction

London Stock Exchange

 

 

For more information please contact:

 

Chris Fussell

General Counsel and Company Secretary

Tel: +44 (0) 203 058 3546

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHUGUCGGUPRGGB
Date   Source Headline
23rd Sep 20211:51 pmRNSHolding(s) in Company
23rd Sep 20211:46 pmRNSHolding(s) in Company
20th Sep 20214:36 pmRNSPrice Monitoring Extension
2nd Aug 20217:00 amRNSDirectorate Change
2nd Aug 20217:00 amRNSHalf-year Report
22nd Jun 202110:42 amRNSHolding(s) in Company
22nd Jun 20218:00 amRNSDirectorate Change
21st Jun 20211:03 pmRNSHolding(s) in Company
11th Jun 20214:01 pmRNSHolding(s) in Company
3rd Jun 20211:14 pmRNSHolding(s) in Company
3rd Jun 202111:26 amRNSHolding(s) in Company
2nd Jun 202110:21 amRNSHolding(s) in Company
1st Jun 20218:58 amRNSHolding(s) in Company
19th May 20212:25 pmRNSDirector/PDMR Shareholding
19th May 202111:52 amRNSResult of AGM
19th May 20217:00 amRNSTrading Statement
7th May 202111:00 amRNSTotal Voting Rights
16th Apr 20213:25 pmRNSNotice of AGM
13th Apr 20214:40 pmRNSSecond Price Monitoring Extn
13th Apr 20214:35 pmRNSPrice Monitoring Extension
13th Apr 20214:17 pmRNSDirector/PDMR Shareholding
12th Apr 20211:43 pmRNSDirectorate Change
9th Apr 20213:37 pmRNSDirector/PDMR Shareholding
6th Apr 20212:52 pmRNSBlock listing Interim Review
31st Mar 20211:38 pmRNSAnnual Financial Report
30th Mar 20217:00 amRNSFinal Results
20th Jan 20211:02 pmRNSHolding(s) in Company
30th Dec 20204:41 pmRNSSecond Price Monitoring Extn
30th Dec 20204:35 pmRNSPrice Monitoring Extension
9th Dec 20207:00 amRNSTrading Statement
7th Oct 202010:25 amRNSHolding(s) in Company
2nd Oct 202011:11 amRNSConfirmation of CFO appointment
30th Sep 20209:22 amRNSBlock listing Interim Review
21st Sep 20204:21 pmRNSHolding(s) in Company
1st Sep 20205:51 pmRNSTotal Voting Rights
1st Sep 20205:47 pmRNSDirector/PDMR Shareholding
5th Aug 202010:06 amRNSHolding(s) in Company
5th Aug 202010:01 amRNSHolding(s) in Company
3rd Aug 20207:00 amRNSHalf-year Report
31st Jul 202010:00 amRNSHolding(s) in Company
25th Jun 20204:40 pmRNSSecond Price Monitoring Extn
25th Jun 20204:35 pmRNSPrice Monitoring Extension
17th Jun 202010:12 amRNSHolding(s) in Company
16th Jun 20207:00 amRNSTrading Statement
12th Jun 20209:45 amRNSHolding(s) in Company
9th Jun 202010:31 amRNSHolding(s) in Company
5th Jun 20204:41 pmRNSSecond Price Monitoring Extn
5th Jun 20204:36 pmRNSPrice Monitoring Extension
3rd Jun 20207:00 amRNSDirectorate Change - CFO appointment
21st May 202012:07 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.